Amended Statement of Beneficial Ownership (3/a)

Date : 05/08/2019 @ 12:41AM
Source : Edgar (US Regulatory)
Stock : Merck & Company (New) (MRK)
Quote : 81.92  0.33 (0.40%) @ 10:45PM

Amended Statement of Beneficial Ownership (3/a)

FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Nally Michael

2. Date of Event Requiring Statement (MM/DD/YYYY)
1/1/2019 

3. Issuer Name and Ticker or Trading Symbol

Merck & Co., Inc. [MRK]

(Last)        (First)        (Middle)

MERCK & CO., INC., 2000 GALLOPING HILL ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
EVP, Chief Marketing Officer /

(Street)

KENILWORTH, NJ 07033       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

1/10/2019 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   100.0000   (1) D    
Common Stock - 401(k) Plan   1365.9535   (2) I   By 401(k)  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit   5/4/2019   (3) 5/4/2021   Common Stock   3896.0000     (4) D    
Restricted Stock Unit   5/10/2019   5/10/2019   Common Stock   1811.0000     (4) D    
Restricted Stock Unit   10/30/2019   (5) 10/30/2021   Common Stock   6862.0000     (4) D    
Restricted Stock Unit   5/5/2020   5/5/2020   Common Stock   2345.0000     (4) D    
Stock Option (right to buy)   5/10/2017   (6) 5/9/2026   Common Stock   7471.0000   $54.6800   D    
Stock Option (right to buy)   5/4/2019   (7) 5/3/2028   Common Stock   27447.0000   $57.7500   D    
Stock Option (right to buy)   5/5/2018   (8) 5/4/2027   Common Stock   14266.0000   $63.9700   D    

Explanation of Responses:
(1)  The original Form 3, filed on January 10, 2019, is being amended by this Form 3 amendment solely to correct the total number of shares beneficially owned by the reporting person to include 100 shares of Merck common stock held in a joint account with the reporting person and the reporting person's parent.
(2)  Includes shares acquired and dividends earned through January 1, 2019, in the Merck U.S. Savings Plan, a 401(k) plan.
(3)  These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
(4)  Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
(5)  These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
(6)  The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019.
(7)  The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
(8)  The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/19 and 5/5/2020.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Nally Michael
MERCK & CO., INC.
2000 GALLOPING HILL ROAD
KENILWORTH, NJ 07033


EVP, Chief Marketing Officer

Signatures
Faye C. Brown as Attorney-in-Fact for Michael Nally 5/7/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Merck (NYSE:MRK)
Historical Stock Chart

1 Year : From Jul 2018 to Jul 2019

Click Here for more Merck Charts.

Merck (NYSE:MRK)
Intraday Stock Chart

Today : Wednesday 17 July 2019

Click Here for more Merck Charts.

Latest MRK Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.